Inhibition of tyrosine kinase activity by SUGEN 5416 inhibits fibrin dependent angiogenesis.
Publication
, Journal Article
Haroon, ZA; Amin, K; Hu, J; Greenberg, CS; Dewhirst, MW
Published in: BLOOD
November 16, 2000
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2000
Volume
96
Issue
11
Start / End Page
57B / 57B
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Haroon, Z. A., Amin, K., Hu, J., Greenberg, C. S., & Dewhirst, M. W. (2000). Inhibition of tyrosine kinase activity by SUGEN 5416 inhibits fibrin dependent angiogenesis. BLOOD, 96(11), 57B-57B.
Haroon, Z. A., K. Amin, J. Hu, C. S. Greenberg, and M. W. Dewhirst. “Inhibition of tyrosine kinase activity by SUGEN 5416 inhibits fibrin dependent angiogenesis.” BLOOD 96, no. 11 (November 16, 2000): 57B-57B.
Haroon ZA, Amin K, Hu J, Greenberg CS, Dewhirst MW. Inhibition of tyrosine kinase activity by SUGEN 5416 inhibits fibrin dependent angiogenesis. BLOOD. 2000 Nov 16;96(11):57B-57B.
Haroon, Z. A., et al. “Inhibition of tyrosine kinase activity by SUGEN 5416 inhibits fibrin dependent angiogenesis.” BLOOD, vol. 96, no. 11, AMER SOC HEMATOLOGY, Nov. 2000, pp. 57B-57B.
Haroon ZA, Amin K, Hu J, Greenberg CS, Dewhirst MW. Inhibition of tyrosine kinase activity by SUGEN 5416 inhibits fibrin dependent angiogenesis. BLOOD. AMER SOC HEMATOLOGY; 2000 Nov 16;96(11):57B-57B.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2000
Volume
96
Issue
11
Start / End Page
57B / 57B
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology